BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M, Hushmandi K, Sethi G, Zarrabi A, Kumar AP, Tan SC, Papadakis M, Alexiou A, Islam MA, Mostafavi E, Ashrafizadeh M. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol 2022;15:83. [PMID: 35765040 DOI: 10.1186/s13045-022-01305-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabouni E, Nejad MM, Mojtabavi S, Khoshduz S, Mojtabavi M, Nadafzadeh N, Nikpanjeh N, Mirzaei S, Hashemi M, Aref AR, Khorrami R, Nabavi N, Ertas YN, Salimimoghadam S, Zandieh MA, Rahmanian P, Taheriazam A, Hushmandi K. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways. Biomed Pharmacother 2023;160:114395. [PMID: 36804124 DOI: 10.1016/j.biopha.2023.114395] [Reference Citation Analysis]
2 Yi Q, Xu Z, Thakur A, Zhang K, Liang Q, Liu Y, Yan Y. Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment. Pharmacol Res 2023;190:106733. [PMID: 36931541 DOI: 10.1016/j.phrs.2023.106733] [Reference Citation Analysis]
3 Kang Y, Li S. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol 2023;230:123159. [PMID: 36610572 DOI: 10.1016/j.ijbiomac.2023.123159] [Reference Citation Analysis]
4 Guo X, Gao C, Yang DH, Li S. Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance. Drug Resist Updat 2023;67:100937. [PMID: 36753923 DOI: 10.1016/j.drup.2023.100937] [Reference Citation Analysis]
5 Wu Q, Ding Q, Lin W, Weng Y, Feng S, Chen R, Chen C, Qiu S, Lin D. Profiling of Tumor Cell-Delivered Exosome by Surface Enhanced Raman Spectroscopy-Based Biosensor for Evaluation of Nasopharyngeal Cancer Radioresistance. Adv Healthc Mater 2023;12:e2202482. [PMID: 36528342 DOI: 10.1002/adhm.202202482] [Reference Citation Analysis]
6 Chen R, Cheng Y, Zhang W, Zhang H, Yuan X. The biological applications of exosomal-based materials in bone/cartilage tissue engineering. Front Mater 2023;10. [DOI: 10.3389/fmats.2023.1152378] [Reference Citation Analysis]
7 Zheng W, Zhu T, Tang L, Li Z, Jiang G, Huang X. Inhalable CAR-T Cell-Derived Exosomes as Paclitaxel Carriers for Treating Lung Cancer.. [DOI: 10.21203/rs.3.rs-2494599/v1] [Reference Citation Analysis]
8 Palumbo C, Benvenuto M, Focaccetti C, Albonici L, Cifaldi L, Rufini A, Nardozi D, Angiolini V, Bei A, Masuelli L, Bei R. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma. Front Med (Lausanne) 2023;10:1066021. [PMID: 36817764 DOI: 10.3389/fmed.2023.1066021] [Reference Citation Analysis]
9 Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomed Pharmacother 2023;158:114168. [PMID: 36916439 DOI: 10.1016/j.biopha.2022.114168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hashemi M, Etemad S, Rezaei S, Ziaolhagh S, Rajabi R, Rahmanian P, Abdi S, Koohpar ZK, Rafiei R, Raei B, Ahmadi F, Salimimoghadam S, Aref AR, Zandieh MA, Entezari M, Taheriazam A, Hushmandi K. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions. Biomed Pharmacother 2023;158:114204. [PMID: 36916430 DOI: 10.1016/j.biopha.2022.114204] [Reference Citation Analysis]
11 Peng Y, Li Z, Fu Y, Pan Y, Zeng Y, Liu J, Xiao C, Zhang Y, Su Y, Li G, Wu F. Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer. Front Oncol 2023;13:1011810. [PMID: 36761954 DOI: 10.3389/fonc.2023.1011810] [Reference Citation Analysis]
12 Xiao G, Xu Z, Luo F. Combinational antitumor strategies of exosomes as drug carriers: Mini review. Front Pharmacol 2022;13:1107329. [PMID: 36744207 DOI: 10.3389/fphar.2022.1107329] [Reference Citation Analysis]
13 Stefańska K, Józkowiak M, Angelova Volponi A, Shibli JA, Golkar-Narenji A, Antosik P, Bukowska D, Piotrowska-Kempisty H, Mozdziak P, Dzięgiel P, Podhorska-Okołów M, Zabel M, Dyszkiewicz-Konwińska M, Kempisty B. The Role of Exosomes in Human Carcinogenesis and Cancer Therapy-Recent Findings from Molecular and Clinical Research. Cells 2023;12. [PMID: 36766698 DOI: 10.3390/cells12030356] [Reference Citation Analysis]
14 Kim B, Kim KM. Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer. Cancers (Basel) 2023;15. [PMID: 36672418 DOI: 10.3390/cancers15020469] [Reference Citation Analysis]
15 Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res 2023;187:106553. [PMID: 36400343 DOI: 10.1016/j.phrs.2022.106553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hashemi M, Mirzaei S, Zandieh MA, Rezaei S, Amirabbas Kakavand, Dehghanpour A, Esmaeili N, Ghahremanzade A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Ahn KS. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Prog Biophys Mol Biol 2023;177:207-28. [PMID: 36584761 DOI: 10.1016/j.pbiomolbio.2022.12.004] [Reference Citation Analysis]
17 Zandieh MA, Farahani MH, Rajabi R, Avval ST, Karimi K, Rahmanian P, Razzazan M, Javanshir S, Mirzaei S, Paskeh MDA, Salimimoghadam S, Hushmandi K, Taheriazam A, Pandey V, Hashemi M. Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives. Pharmacol Res 2023;187:106582. [PMID: 36436707 DOI: 10.1016/j.phrs.2022.106582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Evdokimova V, Gassmann H, Radvanyi L, Burdach SEG. Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma. Cancers (Basel) 2022;15. [PMID: 36612267 DOI: 10.3390/cancers15010272] [Reference Citation Analysis]
19 Yunusova N, Dzhugashvili E, Yalovaya A, Kolomiets L, Shefer A, Grigor'eva A, Tupikin A, Kondakova I, Tamkovich S. Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients. Int J Mol Sci 2022;24. [PMID: 36613908 DOI: 10.3390/ijms24010464] [Reference Citation Analysis]
20 Bryant P, Sikavitsas VI. Cancer Exosomes: An Overview and the Applications of Flow. Fluids 2022;8:7. [DOI: 10.3390/fluids8010007] [Reference Citation Analysis]
21 Xu J, Xu Y, Ye G, Qiu J. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis. J Chemother 2022;:1-12. [PMID: 36548909 DOI: 10.1080/1120009X.2022.2157618] [Reference Citation Analysis]
22 Fang H, Liu M, Jiang W. Nickel-Doped Microfluidic Chip for Rapid and Efficient Immunomagnetic Separation and Detection of Breast Cancer Cell-Derived Exosomes. Appl Biochem Biotechnol 2022. [DOI: 10.1007/s12010-022-04272-1] [Reference Citation Analysis]
23 Shengbo Han, Decai Wang, Yan Huang, Zhu Zeng, Peng Xu, Hewei Xiong, Zunxiang Ke, Ya Zhang, Yuhang Hu, Fan Wang, Jie Wang, Yong Zhao, Wenfeng Zhuo, Gang Zhao. A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer. J Exp Clin Cancer Res 2022;41:348. [PMID: 36522730 DOI: 10.1186/s13046-022-02556-2] [Reference Citation Analysis]
24 Matsuzaka Y, Yashiro R. Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments. Membranes (Basel) 2022;12. [PMID: 36557150 DOI: 10.3390/membranes12121244] [Reference Citation Analysis]
25 Fu Y, Liu Y, Liu K, Tan L. Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK. Mol Biotechnol 2022. [DOI: 10.1007/s12033-022-00607-9] [Reference Citation Analysis]
26 Wei F, Li Y. The emerging roles of exosome-derived noncoding RNAs in the tumor immune microenvironment and their future applications. Biomedicine & Pharmacotherapy 2022;156:113863. [DOI: 10.1016/j.biopha.2022.113863] [Reference Citation Analysis]
27 Li SC, Kabeer MH. Caveolae-Mediated Extracellular Vesicle (CMEV) Signaling of Polyvalent Polysaccharide Vaccination: A Host-Pathogen Interface Hypothesis. Pharmaceutics 2022;14. [PMID: 36559147 DOI: 10.3390/pharmaceutics14122653] [Reference Citation Analysis]
28 Cui M, Liu Y, Cheng L, Li T, Deng Y, Liu D. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1050917] [Reference Citation Analysis]
29 Ma Y, He X, Di Y, Liu S, Zhan Q, Bai Z, Qiu T, Corpe C, Wang J. Identification of prognostic immune-related lncRNAs in pancreatic cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1005695] [Reference Citation Analysis]
30 Wu W, Wang S, Zhang L, Mao B, Wang B, Wang X, Zhao D, Zhao P, Mou Y, Yan P. Mechanistic studies of MALAT1 in respiratory diseases. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.1031861] [Reference Citation Analysis]
31 Hashemi M, Hajimazdarany S, Mohan CD, Mohammadi M, Rezaei S, Olyaee Y, Goldoost Y, Ghorbani A, Mirmazloomi SR, Gholinia N, Kakavand A, Salimimoghadam S, Ertas YN, Rangappa KS, Taheriazam A, Entezari M. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106535] [Reference Citation Analysis]
32 Khan SU, Khan MU, Gao Y, Khan MI, Puswal SM, Zubair M, Khan MA, Farwa R, Gao S, Ali R, Hussain N. Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy. OpenNano 2022;8:100091. [DOI: 10.1016/j.onano.2022.100091] [Reference Citation Analysis]
33 Ding M, Zhao X, Chen X, Diao W, Kan Y, Cao W, Chen W, Jiang B, Qin H, Gao J, Zhuang J, Zhang Q, Guo H. Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p. Cell Death Discov 2022;8:439. [PMID: 36319622 DOI: 10.1038/s41420-022-01219-7] [Reference Citation Analysis]
34 Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Entezari M, Taheriazam A, Hushmandi K. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomedicine & Pharmacotherapy 2022;155:113774. [DOI: 10.1016/j.biopha.2022.113774] [Reference Citation Analysis]
35 Aili Y, Maimaitiming N, Qin H, Ji W, Fan G, Wang Z, Wang Y. Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application. Front Oncol 2022;12:983878. [DOI: 10.3389/fonc.2022.983878] [Reference Citation Analysis]
36 Wang H, Min J, Liu J, Xu C, Liu Y, Yu Z, Gong A, Xu M. Hypoxia-elicited exosomes promote the chemoresistance of pancreatic cancer cells by transferring lncROR via Hippo signaling.. [DOI: 10.21203/rs.3.rs-2092052/v1] [Reference Citation Analysis]
37 Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother 2022;154:113609. [PMID: 36037786 DOI: 10.1016/j.biopha.2022.113609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
38 Berlanga-Acosta J, Fernandez-Mayola M, Mendoza-Mari Y, Garcia-Ojalvo A, Martinez-Jimenez I, Rodriguez-Rodriguez N, Garcia Del Barco Herrera D, Guillén-Nieto G. Cell-Free Filtrates (CFF) as Vectors of a Transmissible Pathologic Tissue Memory Code: A Hypothetical and Narrative Review. Int J Mol Sci 2022;23:11575. [PMID: 36232877 DOI: 10.3390/ijms231911575] [Reference Citation Analysis]
39 Guo L, Xu N, Qiu D, Yang X, Zhao S, Zhao H. Comprehensive analysis of m6A-modified circRNAs in peritoneal metastasis of high grade serious carcinoma of ovary. Front Oncol 2022;12:988578. [DOI: 10.3389/fonc.2022.988578] [Reference Citation Analysis]
40 Karamichali E, Foka P, Papadopoulou G, Loukaki-Gkountara D, Andresaki K, Koskinas I, Georgopoulou U. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. Int J Mol Sci 2022;23:10862. [PMID: 36142773 DOI: 10.3390/ijms231810862] [Reference Citation Analysis]
41 Bae J, Kim JH. Exosome Release by Glucose Deprivation Is Important for the Viability of TSC-Null Cells. Cells 2022;11:2862. [DOI: 10.3390/cells11182862] [Reference Citation Analysis]
42 Ye Q, Li L, Shao Z, Xu M, Li L, Yan Q, Huang B, Zhao T. Association between lncRNAs in plasma exosomes and diabetic retinopathy. Front Endocrinol 2022;13:987488. [DOI: 10.3389/fendo.2022.987488] [Reference Citation Analysis]
43 Luo N, Zhong W, Li J, Zhai Z, Lu J, Dong R. Targeted activation of HNF4α/HGF1/FOXA2 reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system. Nanomedicine (Lond) 2022;17:1411-27. [PMID: 36326013 DOI: 10.2217/nnm-2022-0083] [Reference Citation Analysis]
44 Kapoor-Narula U, Lenka N. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. Cytokine 2022;157:155968. [PMID: 35872504 DOI: 10.1016/j.cyto.2022.155968] [Reference Citation Analysis]